<DOC>
	<DOCNO>NCT00687284</DOCNO>
	<brief_summary>This study conduct Europe . An observational study evaluate glycaemic control patient use Levemir® initiation insulin therapy treatment type 2 diabetes Slovakia .</brief_summary>
	<brief_title>Observational Study Glycaemic Control Patients Uncontrolled Oral Antidiabetic Agents Starting With 1 ( Once ) Daily Levemir® ( Insulin Detemir ) Treatment Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Patients type 2 diabetes Patients inadequately control OAD Patients willing sign inform consent Selection study participant discretion physician Particular attention pay drug interaction list within product label Subjects unlikely comply protocol , e.g. , uncooperative attitude , inability return final visit ; Subjects previously enrol study Subjects hypersensitivity insulin detemir excipients . Women pregnant , breastfeed intention become pregnant within next 6 month</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>